Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Korro Bio (KRRO) EPS (Basic) (2019 - 2025)

Korro Bio (KRRO) has disclosed EPS (Basic) for 6 consecutive years, with -$1.92 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EPS (Basic) rose 15.04% year-over-year to -$1.92, compared with a TTM value of -$9.42 through Sep 2025, down 106.69%, and an annual FY2024 reading of -$9.37, up 82.35% over the prior year.
  • EPS (Basic) was -$1.92 for Q3 2025 at Korro Bio, up from -$2.75 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $147.86 in Q4 2023 and bottomed at -$225.59 in Q4 2022.
  • Average EPS (Basic) over 5 years is -$12.36, with a median of -$1.92 recorded in 2025.
  • The sharpest move saw EPS (Basic) plummeted 36285.48% in 2022, then soared 165.54% in 2023.
  • Year by year, EPS (Basic) stood at -$0.62 in 2021, then tumbled by 36285.48% to -$225.59 in 2022, then soared by 165.54% to $147.86 in 2023, then plummeted by 101.53% to -$2.26 in 2024, then grew by 15.04% to -$1.92 in 2025.
  • Business Quant data shows EPS (Basic) for KRRO at -$1.92 in Q3 2025, -$2.75 in Q2 2025, and -$2.49 in Q1 2025.